WallStreetZenWallStreetZen

NASDAQ: AXSM
Axsome Therapeutics Inc Stock

$79.17+2.45 (+3.19%)
Updated Mar 27, 2024
AXSM Price
$79.17
Fair Value Price
$89.18
Market Cap
$3.75B
52 Week Low
$55.02
52 Week High
$98.40
P/E
-15.02x
P/B
19.64x
P/S
13.36x
PEG
N/A
Dividend Yield
N/A
Revenue
$270.60M
Earnings
-$239.24M
Gross Margin
90.4%
Operating Margin
-85.67%
Profit Margin
-88.4%
Debt to Equity
2.08
Operating Cash Flow
-$145M
Beta
1.01
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AXSM Overview

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial for the treatment of smoking cessation. It is also developing AXS-07, a novel, oral, rapidly absorbed, multi-mechanistic, and investigational medicine that has completed two Phase III trials for the acute treatment of migraine; AXS-12, a selective and potent norepinephrine reuptake inhibitor, which is in Phase III trial to treat narcolepsy; and AXS-14, a novel, oral, and investigational medicine that is in Phase III trial for the treatment of fibromyalgia. Axsome Therapeutics, Inc. has a research collaboration agreement with Duke University for evaluating AXS-05 in smoking cessation. The company was incorporated in 2012 and is based in New York, New York.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AXSM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AXSM ($79.17) is undervalued by 11.22% relative to our estimate of its Fair Value price of $89.18 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
AXSM ($79.17) is not significantly undervalued (11.22%) relative to our estimate of its Fair Value price of $89.18 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AXSM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AXSM due diligence checks available for Premium users.

Be the first to know about important AXSM news, forecast changes, insider trades & much more!

AXSM News

Valuation

AXSM fair value

Fair Value of AXSM stock based on Discounted Cash Flow (DCF)
Price
$79.17
Fair Value
$89.18
Undervalued by
11.22%
AXSM ($79.17) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AXSM ($79.17) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AXSM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AXSM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-15.02x
Industry
14.3x
Market
44.45x

AXSM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
19.64x
Industry
6.2x
AXSM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AXSM's financial health

Profit margin

Revenue
$71.5M
Net Income
-$98.7M
Profit Margin
-137.9%
AXSM's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
AXSM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$588.2M
Liabilities
$397.3M
Debt to equity
2.08
AXSM's short-term assets ($504.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AXSM's short-term assets ($504.26M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AXSM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AXSM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$30.4M
Investing
-$7.0k
Financing
-$2.0k
AXSM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AXSM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
AXSM$3.75B+3.19%-15.02x19.64x
ACLX$3.72B+0.46%-47.93x7.66x
SWTX$3.70B+1.83%-9.73x5.90x
IBRX$3.68B+6.64%-4.75x-6.27x
RARE$3.85B+2.99%-5.68x14.00x

Axsome Therapeutics Stock FAQ

What is Axsome Therapeutics's quote symbol?

(NASDAQ: AXSM) Axsome Therapeutics trades on the NASDAQ under the ticker symbol AXSM. Axsome Therapeutics stock quotes can also be displayed as NASDAQ: AXSM.

If you're new to stock investing, here's how to buy Axsome Therapeutics stock.

What is the 52 week high and low for Axsome Therapeutics (NASDAQ: AXSM)?

(NASDAQ: AXSM) Axsome Therapeutics's 52-week high was $98.40, and its 52-week low was $55.02. It is currently -19.54% from its 52-week high and 43.89% from its 52-week low.

How much is Axsome Therapeutics stock worth today?

(NASDAQ: AXSM) Axsome Therapeutics currently has 47,374,375 outstanding shares. With Axsome Therapeutics stock trading at $79.17 per share, the total value of Axsome Therapeutics stock (market capitalization) is $3.75B.

Axsome Therapeutics stock was originally listed at a price of $8.74 in Nov 19, 2015. If you had invested in Axsome Therapeutics stock at $8.74, your return over the last 8 years would have been 805.84%, for an annualized return of 31.71% (not including any dividends or dividend reinvestments).

How much is Axsome Therapeutics's stock price per share?

(NASDAQ: AXSM) Axsome Therapeutics stock price per share is $79.17 today (as of Mar 27, 2024).

What is Axsome Therapeutics's Market Cap?

(NASDAQ: AXSM) Axsome Therapeutics's market cap is $3.75B, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Axsome Therapeutics's market cap is calculated by multiplying AXSM's current stock price of $79.17 by AXSM's total outstanding shares of 47,374,375.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.